Home » Products » Anti Cancer Injection » CETUXIMAB 100MG

CETUXIMAB 100MG

CETUXIMAB 100MG
CETUXIMAB 100MG
Send Inquiry
Product Code : 65
Brand Name : ERBITUX 100MG
Price And Quantity
  • Minimum Order Quantity
  • 5 Bottle
  • Price
  • 14000 INR
  • Price Range
  • 14500.00 - 14000.00 INR
Product Description


Privacy & Trust Info

Drug Description


ERBITUX®
(cetuximab) Injection

WARNING

SERIOUS INFUSION REACTIONS and CARDIOPULMONARY ARREST

Infusion Reactions: Serious infusion reactions occurred with the administration of ERBITUX in approximately 3% of patients in clinical trials, with fatal outcome reported in less than 1 in 1000 [see WARNINGS AND PRECAUTIONSADVERSE REACTIONS]. Immediately interrupt and permanently discontinue ERBITUX infusion for serious infusion reactions [see DOSAGE AND ADMINISTRATION, WARNINGS AND PRECAUTIONS]. Cardiopulmonary Arrest: Cardiopulmonary arrest and/or sudden death occurred in 2% of patients with squamous cell carcinoma of the head and neck treated with ERBITUX and radiation therapy in Study 1 and in 3% of patients with squamous cell carcinoma of the head and neck treated with European Union (EU)- approved cetuximab in combination with platinum-based therapy with 5-fluorouracil (5-FU) in Study 2. Closely monitor serum electrolytes, including serum magnesium, potassium, and calcium, during and after ERBITUX administration [see WARNINGS AND PRECAUTIONSClinical Studies].

DESCRIPTION

ERBITUX® (cetuximab) is a recombinant, human/mouse chimeric monoclonal antibody that binds specifically to the extracellular domain of the human epidermal growth factor receptor (EGFR). Cetuximab is composed of the Fv regions of a murine anti-EGFR antibody with human IgG1 heavy and kappa light chain constant regions and has an approximate molecular weight of 152 kDa. Cetuximab is produced in mammalian (murine myeloma) cell culture. ERBITUX is a sterile, clear, colorless liquid of pH 7.0 to 7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulates. ERBITUX is supplied at a concentration of 2 mg/mL in either 100 mg (50 mL) or 200 mg (100 mL), single-use vials. Cetuximab is formulated in a solution with no preservatives, which contains 8.48 mg/mL sodium chloride, 1.88 mg/mL sodium phosphate dibasic heptahydrate, 0.41 mg/mL sodium phosphate monobasic monohydrate, and Water for Injection, USP.

Trade Information
  • FOB Port
  • NEW DELHI
  • Payment Terms
  • Western Union, Delivery Point (DP), Cheque, Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD), Cash Against Delivery (CAD)
  • Supply Ability
  • 20 Bottle Per Day
  • Delivery Time
  • 1-2 Days
  • Main Domestic Market
  • All India

NEXT GEN BIOTECH
X


Back to top
NEXT GEN BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.